Journal of Jilin University(Medicine Edition) ›› 2026, Vol. 52 ›› Issue (1): 143-151.doi: 10.13481/j.1671-587X.20260115
• Research in basic medicine • Previous Articles Next Articles
Yunshan DING,Haitao DAI,Min CHEN,Xiaohui HAO,Xiao ZHOU,Nan WU(
)
Received:2025-03-10
Accepted:2025-05-16
Online:2026-01-28
Published:2026-02-24
Contact:
Nan WU
E-mail:195773220@qq.com
CLC Number:
Yunshan DING,Haitao DAI,Min CHEN,Xiaohui HAO,Xiao ZHOU,Nan WU. Effect of silencing TRPV2 gene and cannabidiol on biological behaviors of oral squamous cell carcinoma CAL-27 cells[J].Journal of Jilin University(Medicine Edition), 2026, 52(1): 143-151.
Tab.1
Survival rates of CAL-27 cells in various groups after treated with different doses of CBD for 24, 48, 72, and 96 h"
| Group | Survival rate | |||
|---|---|---|---|---|
| (t/h) 24 | 48 | 72 | 96 | |
| CBD (μmol·L-1) | ||||
| 0 | 100.00±11.84 | 100.00±6.61 | 100.00±7.54 | 100.00±12.08 |
| 10 | 96.98±7.41 | 108.70±17.11 | 118.50±4.76* | 100.80±15.30 |
| 20 | 35.35±1.91* | 17.06±15.87* | 4.36±0.19* | 3.98±0.64* |
| 40 | 16.95±0.94* | 10.29±5.07* | 3.99±1.26* | 2.84±1.65* |
| [1] | SUNG H, FERLAY J, SIEGEL R L, et al. Global cancer statistics 2020: GLOBOCAN estimates of Incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. |
| [2] | MCCORD C, KISS A, MAGALHAES M A, et al. Oral squamous cell carcinoma associated with precursor lesions[J]. Cancer Prev Res (Phila), 2021, 14(9): 873-884. |
| [3] | 孙铭泽, 史佳帆, 刘璐璐, 等. 光热联合疗法在OSCC中的研究进展[J]. 临床口腔医学杂志, 2024, 40(10): 635-637. |
| [4] | GUPTA S, SINGH A, DEORAH S, et al. Immunotherapy in OSCC: Current trend and challenges[J]. Crit Rev Oncol Hematol, 2025, 209: 104672. |
| [5] | SHI E Y, SHAN T H, WANG H P, et al. A bacterial nanomedicine combines photodynamic-immunotherapy and chemotherapy for enhanced treatment of oral squamous cell carcinoma[J]. Small, 2023, 19(52): e2304014. |
| [6] | Bharadwaj R, SAHU B P, HALOI J, et al. Combinatorial therapeutic approach for treatment of oral squamous cell carcinoma[J]. Artif Cells Nanomed Biotechnol, 2019, 47(1): 572-585. |
| [7] | DADON D, MINKE B. Cellular functions of transient receptor potential channels [J]. Int J Biochem Cell Biol, 2010, 42(9): 1430-1445. |
| [8] | MISRI S, KAUL K, MISHRA S, et al. Cannabidiol inhibits tumorigenesis in cisplatin-resistant non-small cell lung cancer via TRPV2[J]. Cancers, 2022, 14(5): 1181. |
| [9] | MORELLI M B, NABISSI M, AMANTINI C, et al. The transient receptor potential vanilloid-2 cation channel impairs glioblastoma stem-like cell proliferation and promotes differentiation[J]. Int J Cancer, 2012, 131(7): E1067-E1077. |
| [10] | MARINELLI O, MORELLI M B, ANNIBALI D, et al. The effects of cannabidiol and prognostic role of TRPV2 in human endometrial cancer[J]. Int J Mol Sci, 2020, 21(15): 5409. |
| [11] | KATO S, SHIOZAKI A, KUDOU M, et al. TRPV2 promotes cell migration and invasion in gastric cancer via the transforming growth factor-β signaling pathway[J]. Ann Surg Oncol, 2022, 29(5): 2944-2956. |
| [12] | ZHANG W, HE X, YIN H, et al. Allosteric activation of the metabolic enzyme GPD1 inhibits bladder cancer growth via the lysoPC-PAFR-TRPV2 axis[J]. J Hematol Oncol, 2022, 15(1): 93. |
| [13] | SANTONI G, AMANTINI C, MAGGI F, et al. The TRPV2 cation channels: from urothelial cancer invasiveness to glioblastoma multiforme interactome signature[J]. Lab Investig, 2020, 100(2): 186-198. |
| [14] | 王 亚, 张林杰, 仵 楠, 等. 口腔鳞状细胞癌中TRPV2的表达及其临床病理意义[J]. 实用医学杂志, 2023, 39(15): 1913-1918. |
| [15] | 祖木热提古丽·阿不来提, 陈镭雨, 马琰迪, 等. TRPV4和TGF-β1在口腔鳞状细胞癌中的表达及临床意义[J]. 实用口腔医学杂志, 2022, 38(6): 743-747. |
| [16] | LANDUCCI E, PELLEGRINI-GIAMPIETRO D E, GIANONCELLI A, et al. Cannabidiol preferentially binds TRPV2: a novel mechanism of action[J]. Neural Regen Res, 2022, 17(12): 2693-2694. |
| [17] | MELO E S A, ASEVEDO E A, DUARTE-ALMEIDA J M, et al. Mechanisms of cell death induced by cannabidiol against tumor cells: a review of preclinical studies[J]. Plants, 2025, 14(4): 585. |
| [18] | GHOSH S, SHAH P A, JOHNSON F M. Novel systemic treatment modalities including immunotherapy and molecular targeted therapy for recurrent and metastatic head and neck squamous cell carcinoma[J]. Int J Mol Sci, 2022, 23(14): 7889. |
| [19] | LI Q, LI H X, ZHU R W, et al. TRPV2 calcium channel promotes breast cancer progression potential by activating autophagy[J]. Cancer Cell Int, 2024, 24(1): 324. |
| [20] | SHOJI K F, BAYET E, LEVERRIER-PENNA S, et al. The mechanosensitive TRPV2 calcium channel promotes human melanoma invasiveness and metastatic potential[J]. EMBO Rep, 2023, 24(4): e55069. |
| [21] | HEIDER C G, ITENBERG S A, RAO J J, et al. Mechanisms of cannabidiol (CBD) in cancer treatment: a review [J]. Biology, 2022, 11(6): 817. |
| [22] | LI Y T, SHARMA A, HOFFMANN M J, et al. Discovering single cannabidiol or synergistic antitumor effects of cannabidiol and cytokine-induced killer cells on non-small cell lung cancer cells[J]. Front Immunol, 2024, 15: 1268652. |
| [23] | VIERECKL M J, KRUTSINGER K, APAWU A, et al. Cannabidiol and cannabigerol inhibit cholangiocarcinoma growth in vitro via divergent cell death pathways[J]. Biomolecules, 2022, 12(6): 854. |
| [24] | FENG P, ZHU L X F, JIE J, et al. Cannabidiol inhibits invasion and metastasis in colorectal cancer cells by reversing epithelial-mesenchymal transition through the Wnt/β-catenin signaling pathway[J]. J Cancer Res Clin Oncol, 2023, 149(7): 3587-3598. |
| [25] | HUANG T F, XU T Q, WANG Y F, et al. Cannabidiol inhibits human glioma by induction of lethal mitophagy through activating TRPV4[J]. Autophagy, 2021, 17(11): 3592-3606. |
| [26] | PONGKING T, INTUYOD K, THONGPON P, et al. Cannabidiol suppresses proliferation and induces cell death, autophagy and senescence in human cholangiocarcinoma cells via the PI3K/AKT/mTOR pathway[J]. J Tradit Complement Med, 2024, 14(6): 622-634. |
| [27] | PARK Y J, NA H H, KWON I S, et al. Cannabidiol regulates PPARγ-dependent vesicle formation as well as cell death in A549 human lung cancer cells[J]. Pharmaceuticals (Basel), 2022, 15(7): 836. |